Patent Ductus Arteriosus Stenting for All Ductal-Dependent Cyanotic Infants: Waning Use of Blalock-Taussig Shunts

Circ Cardiovasc Interv. 2021 Mar;14(3):e009520. doi: 10.1161/CIRCINTERVENTIONS.120.009520. Epub 2021 Mar 9.

¹ Division of Pediatric Cardiology (K.R., J.W.M., P.W.G., K.B., R.L.W., D.A.G., R.P.R., H.G.E.-S.), Rady Children's Hospital and UC San Diego School of Medicine, CA.
² Division of Pediatric Cardiology, Department of Pediatrics, St. Louis Children's Hospital, Washington University School of Medicine, MO (S.J.N.).
³ Division of Pediatric Cardiology, Baylor College of Medicine, The Children's Hospital of San Antonio, TX (J.W.L.).
⁴ Biostatistics Unit, Altman Clinical and Translational Research Institute, University of California San Diego, CA (H.Y.).
⁵ Division of Cardiovascular Surgery (J.J.N.), Rady Children's Hospital and UC San Diego School of Medicine, CA.

^# Contributed equally.

Abstract

[Figure: see text].

Keywords: congenital heart defects; infant; morbidity; mortality; patent ductus arteriosus; stent; thoracic surgery.